2.Usefulness of the Pipeline Embolic Device for Large and Giant Carotid Cavernous Aneurysms.
Shigeru MIYACHI ; Ryo HIRAMATSU ; Hiroyuki OHNISHI ; Ryokichi YAGI ; Toshihiko KUROIWA
Neurointervention 2017;12(2):83-90
PURPOSE: Conventional coil embolization for large carotid cavernous aneurysms (CCAs) has limited utility due to its inability to prevent recurrences and reduce mass effect. Trapping of the parent artery may have a risk of ischemic complications due to intracranial perfusion disorders. We successfully treated 24 patients with large CCAs using a flow diverter (Pipeline™ embolic device: PED), and this report discusses the safety and efficacy of this method. MATERIALS AND METHODS: Twenty four patients (23 females, mean age 71.5 years old) with large CCAs, including 6 giant CCAs, were treated with a PED over three years. Under sufficient dual anti-platelet management, the PED was deployed over the orifice of the aneurysm. Two patients required multiple telescoping stents. Clinical and radiological states were checked with MRI at 1, 3 and 6 months post-surgically. Angiographic follow-up was performed at 6 months. RESULTS: In all patients, PED was appropriately deployed. Stagnation of contrast with eclipse signs was observed post-angiogram in 21 cases. One patient requiring 5 telescoping stents experienced temporary ischemic symptoms. Fourteen patients experienced improvement of ocular motor impairment deficiency, including 6 patients who recovered. Angiograms at 6 months follow-up showed complete occlusion in 63% (12/19) of patients, and MRI showed reduction of aneurysm volume in 89% (17/19) of patients. CONCLUSION: Flow diverters for large CCAs showed promising clinical and radiological efficacy. They can shrink the aneurysm and improve symptoms without sacrificing the parent artery. It will be necessary to summarize the cases and to verify the long-term results.
Aneurysm*
;
Arteries
;
Embolization, Therapeutic
;
Female
;
Follow-Up Studies
;
Humans
;
Magnetic Resonance Imaging
;
Methods
;
Parents
;
Perfusion
;
Recurrence
;
Stents
3.Endovascular Treatment of Idiopathic Intracranial Hypertension with Stenting of the Transverse Sinus Stenosis.
Shigeru MIYACHI ; Ryo HIRAMATSU ; Hiroyuki OHNISHI ; Kenkichi TAKAHASHI ; Toshihiko KUROIWA
Neurointervention 2018;13(2):138-143
For many years, the pathophysiology of idiopathic intracranial hypertension (IIH) was interpreted as “secondary intracranial hypertension,” and IIH was considered to be caused by brain edema due to obstructive sleep apnea. Another theory proposed cerebrospinal fluid (CSF) absorption impairment due to excessive medication with vitamin A derivatives. Other reports pointed out the importance of obesity, which may cause an impairment of intracranial venous drainage due to elevated right atrial pressure. Patients with medically refractory IIH have traditionally undergone a CSF diversion. Venous outlet impairment on IIH has recently been reported as a causative or contributory cause, and thus focused venoplasty of the stenotic sinus with a stent has emerged as a new treatment strategy. We report the cases of two patients who presented with headache and papilledema with IIH. They successfully underwent stent placement at the stenosis of the transverse sinus and experienced complete resolution of symptoms.
Absorption
;
Atrial Pressure
;
Brain Edema
;
Cerebrospinal Fluid
;
Constriction, Pathologic*
;
Drainage
;
Headache
;
Humans
;
Obesity
;
Papilledema
;
Pseudotumor Cerebri*
;
Sleep Apnea, Obstructive
;
Stents*
;
Vitamin A
4.Verification of grip strength as an evaluation tool for locomotive syndrome in rheumatoid arthritis
Yasumori SOBUE ; Mochihito SUZUKI ; Yoshifumi OHASHI ; Ryo SATO ; Hironobu KOSUGIYAMA ; Yusuke OHNO ; Junya HASEGAWA ; Takaya SUGIURA ; Kenya TERABE ; Shuji ASAI ; Shiro IMAGAMA
Osteoporosis and Sarcopenia 2024;10(3):119-125
Objectives:
Locomotive syndrome (LS) leads to reduced physical function and a high risk of becoming bedridden.Grip strength serves as an indicator of upper limb and overall physical function. Rheumatoid arthritis (RA) patients with reduced grip strength frequently show finger and wrist joint inflammation. The purpose of this study was to verify grip strength as an evaluation tool for physical function and LS in RA patients.
Methods:
As part of an ongoing multicenter observational study, 591 consecutive RA patients whose background information was available, including data for the 25-question Geriatric Locomotive Function Scale (GLFS-25) and grip strength, were examined. LS was defined as a GLFS-25 score ≥ 16 points. Finger and wrist joint inflammation were defined as tender or swollen joints.
Results:
Among the 591 patients, 244 (41.3%) patients had LS, and 167 (28.3%) were male. Receiver operating characteristic curve analysis yielded cut-off values of grip strength for LS of 24 kg (specificity 72.2%; sensitivity 62.7%) for males and 17 kg (specificity 65.7%; sensitivity 67.6%) for females. Multivariable logistic regression analysis revealed a significant association of grip strength with LS, even after adjusting for finger and wrist joint inflammation.
Conclusions
LS was significantly associated with grip strength, even after adjusting for the presence of finger and wrist joint inflammation. We recommend adopting grip strength measurement as a screening tool for evaluating LS and guiding interventions.
5.Verification of grip strength as an evaluation tool for locomotive syndrome in rheumatoid arthritis
Yasumori SOBUE ; Mochihito SUZUKI ; Yoshifumi OHASHI ; Ryo SATO ; Hironobu KOSUGIYAMA ; Yusuke OHNO ; Junya HASEGAWA ; Takaya SUGIURA ; Kenya TERABE ; Shuji ASAI ; Shiro IMAGAMA
Osteoporosis and Sarcopenia 2024;10(3):119-125
Objectives:
Locomotive syndrome (LS) leads to reduced physical function and a high risk of becoming bedridden.Grip strength serves as an indicator of upper limb and overall physical function. Rheumatoid arthritis (RA) patients with reduced grip strength frequently show finger and wrist joint inflammation. The purpose of this study was to verify grip strength as an evaluation tool for physical function and LS in RA patients.
Methods:
As part of an ongoing multicenter observational study, 591 consecutive RA patients whose background information was available, including data for the 25-question Geriatric Locomotive Function Scale (GLFS-25) and grip strength, were examined. LS was defined as a GLFS-25 score ≥ 16 points. Finger and wrist joint inflammation were defined as tender or swollen joints.
Results:
Among the 591 patients, 244 (41.3%) patients had LS, and 167 (28.3%) were male. Receiver operating characteristic curve analysis yielded cut-off values of grip strength for LS of 24 kg (specificity 72.2%; sensitivity 62.7%) for males and 17 kg (specificity 65.7%; sensitivity 67.6%) for females. Multivariable logistic regression analysis revealed a significant association of grip strength with LS, even after adjusting for finger and wrist joint inflammation.
Conclusions
LS was significantly associated with grip strength, even after adjusting for the presence of finger and wrist joint inflammation. We recommend adopting grip strength measurement as a screening tool for evaluating LS and guiding interventions.
6.Verification of grip strength as an evaluation tool for locomotive syndrome in rheumatoid arthritis
Yasumori SOBUE ; Mochihito SUZUKI ; Yoshifumi OHASHI ; Ryo SATO ; Hironobu KOSUGIYAMA ; Yusuke OHNO ; Junya HASEGAWA ; Takaya SUGIURA ; Kenya TERABE ; Shuji ASAI ; Shiro IMAGAMA
Osteoporosis and Sarcopenia 2024;10(3):119-125
Objectives:
Locomotive syndrome (LS) leads to reduced physical function and a high risk of becoming bedridden.Grip strength serves as an indicator of upper limb and overall physical function. Rheumatoid arthritis (RA) patients with reduced grip strength frequently show finger and wrist joint inflammation. The purpose of this study was to verify grip strength as an evaluation tool for physical function and LS in RA patients.
Methods:
As part of an ongoing multicenter observational study, 591 consecutive RA patients whose background information was available, including data for the 25-question Geriatric Locomotive Function Scale (GLFS-25) and grip strength, were examined. LS was defined as a GLFS-25 score ≥ 16 points. Finger and wrist joint inflammation were defined as tender or swollen joints.
Results:
Among the 591 patients, 244 (41.3%) patients had LS, and 167 (28.3%) were male. Receiver operating characteristic curve analysis yielded cut-off values of grip strength for LS of 24 kg (specificity 72.2%; sensitivity 62.7%) for males and 17 kg (specificity 65.7%; sensitivity 67.6%) for females. Multivariable logistic regression analysis revealed a significant association of grip strength with LS, even after adjusting for finger and wrist joint inflammation.
Conclusions
LS was significantly associated with grip strength, even after adjusting for the presence of finger and wrist joint inflammation. We recommend adopting grip strength measurement as a screening tool for evaluating LS and guiding interventions.
7.Verification of grip strength as an evaluation tool for locomotive syndrome in rheumatoid arthritis
Yasumori SOBUE ; Mochihito SUZUKI ; Yoshifumi OHASHI ; Ryo SATO ; Hironobu KOSUGIYAMA ; Yusuke OHNO ; Junya HASEGAWA ; Takaya SUGIURA ; Kenya TERABE ; Shuji ASAI ; Shiro IMAGAMA
Osteoporosis and Sarcopenia 2024;10(3):119-125
Objectives:
Locomotive syndrome (LS) leads to reduced physical function and a high risk of becoming bedridden.Grip strength serves as an indicator of upper limb and overall physical function. Rheumatoid arthritis (RA) patients with reduced grip strength frequently show finger and wrist joint inflammation. The purpose of this study was to verify grip strength as an evaluation tool for physical function and LS in RA patients.
Methods:
As part of an ongoing multicenter observational study, 591 consecutive RA patients whose background information was available, including data for the 25-question Geriatric Locomotive Function Scale (GLFS-25) and grip strength, were examined. LS was defined as a GLFS-25 score ≥ 16 points. Finger and wrist joint inflammation were defined as tender or swollen joints.
Results:
Among the 591 patients, 244 (41.3%) patients had LS, and 167 (28.3%) were male. Receiver operating characteristic curve analysis yielded cut-off values of grip strength for LS of 24 kg (specificity 72.2%; sensitivity 62.7%) for males and 17 kg (specificity 65.7%; sensitivity 67.6%) for females. Multivariable logistic regression analysis revealed a significant association of grip strength with LS, even after adjusting for finger and wrist joint inflammation.
Conclusions
LS was significantly associated with grip strength, even after adjusting for the presence of finger and wrist joint inflammation. We recommend adopting grip strength measurement as a screening tool for evaluating LS and guiding interventions.
8.Outcome Evaluation of a Nationwide Education Program for Primary Palliative Care
Ryo YAMAMOTO ; Yoshiyuki KIZAWA ; Jun NAGAYAMA ; Keiichi UEMURA ; Satofumi SHIMOYAMA
Palliative Care Research 2021;16(1):73-78
Background: In Japan, a nation-wide education program for primary palliative care (the Palliative care Emphasis program on symptom management and Assessment for Continuous medical Education: PEACE) was established in 2008. In 2018, this program was revised from a two-day workshop to a hybrid program combining e-learning with a one-day workshop. This study aimed to assess the changes in participant knowledge and difficulties after having completed the revised education program. Methods: The subjects of this study were all participants who completed the revised program from April 2018 to March 2019. We conducted a pre-post survey via the e-learning system, and measured scores on the palliative care knowledge questionnaire to evaluate PEACE (PEACE-Q) and Palliative Care Difficulties Scale (PCDS). Results: A total of 11,124 participants completed the revised program from June 2018 to March 2019. Participants’ knowledge improved significantly according to the PEACE-Q with a total score of 24.1 and 30.0 (p<0.0001), and difficulties diminished as indicated by the PCDS with a total score of 45.2 and 39.2 (p<0.0001). Participants in different professions obtained similar results. Conclusion: Participants’ knowledge and difficulties improved after the revised nationwide primary palliative care education program. Similar results were obtained by participants in different professions.
9.Effect of a combination of astaxanthin supplementation, heat stress, and intermittent reloading on satellite cells during disuse muscle atrophy.
Toshinori YOSHIHARA ; Takao SUGIURA ; Nobuyuki MIYAJI ; Yuki YAMAMOTO ; Tsubasa SHIBAGUCHI ; Ryo KAKIGI ; Hisashi NAITO ; Katsumasa GOTO ; Daijiro OHMORI ; Toshitada YOSHIOKA
Journal of Zhejiang University. Science. B 2018;19(11):844-852
We examined the effect of a combination of astaxanthin (AX) supplementation, repeated heat stress, and intermittent reloading (IR) on satellite cells in unloaded rat soleus muscles. Forty-nine male Wistar rats (8-week-old) were divided into control, hind-limb unweighting (HU), IR during HU, IR with AX supplementation, IR with repeated heat stress (41.0-41.5 °C for 30 min), and IR with AX supplementation and repeated heat stress groups. After the experimental period, the antigravitational soleus muscle was analyzed using an immunohistochemical technique. Our results revealed that the combination of dietary AX supplementation and heat stress resulted in protection against disuse muscle atrophy in the soleus muscle. This protective effect may be partially due to a higher satellite cell number in the atrophied soleus muscle in the IR/AX/heat stress group compared with the numbers found in the other groups. We concluded that the combination treatment with dietary AX supplementation and repeated heat stress attenuates soleus muscle atrophy, in part by increasing the number of satellite cells.
Animals
;
Body Weight
;
Dietary Supplements
;
Fibrinolytic Agents/pharmacology*
;
Heat-Shock Response
;
Hindlimb
;
Hot Temperature
;
Immunohistochemistry
;
Male
;
Muscle, Skeletal
;
Muscular Atrophy/drug therapy*
;
Oxidative Stress
;
Rats
;
Rats, Wistar
;
Satellite Cells, Skeletal Muscle/cytology*
;
Xanthophylls/pharmacology*